The University of Chicago Header Logo

Connection

Andrew Aronsohn to Humans

Back to Details
This is a "connection" page, showing publications Andrew Aronsohn has written about Humans.
Andrew Aronsohn
Connection Strength
0.390
Humans
  1. Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049.
    View in: PubMed
    Score: 0.030
  2. Identifying Stigma as a Key Initial Step to Equitable Hepatitis C Virus Care. JAMA Netw Open. 2022 12 01; 5(12):e2246610.
    View in: PubMed
    Score: 0.028
  3. IgG 4 Autoimmune Hepatitis Presenting as Idiopathic Hypereosinophilia Syndrome. Hepatology. 2021 04; 73(4):1615-1617.
    View in: PubMed
    Score: 0.025
  4. You Can't Have One Without the Other: Innovation and Ethical Dilemmas in Gastroenterology and Hepatology. Clin Gastroenterol Hepatol. 2021 10; 19(10):2015-2019.
    View in: PubMed
    Score: 0.024
  5. Pay It Forward: Building Capacity to Treat Hepatitis C by Training Our Own Residents. Hepatology. 2018 11; 68(5):2004-2007.
    View in: PubMed
    Score: 0.021
  6. Timing Is Everything: Managing Hepatitis C Virus in Liver Transplant Candidates. Transplantation. 2017 05; 101(5):898-899.
    View in: PubMed
    Score: 0.019
  7. Overcoming injustice: A roadmap to improve access to hepatitis C virus therapy for our medicaid patients. Hepatology. 2017 05; 65(5):1735-1740.
    View in: PubMed
    Score: 0.019
  8. Novel educational interventions in residency increase knowledge of chronic liver disease and career interest in hepatology. Hepatology. 2016 12; 64(6):2210-2218.
    View in: PubMed
    Score: 0.018
  9. Current Management of Chronic Hepatitis B and C in Chronic Kidney Disease. Adv Chronic Kidney Dis. 2015 Sep; 22(5):352-60.
    View in: PubMed
    Score: 0.017
  10. Interferon-combination strategies for the treatment of chronic hepatitis C. Semin Liver Dis. 2014 Feb; 34(1):30-6.
    View in: PubMed
    Score: 0.015
  11. Preparing for the uncertain yet inevitable: off-label combinations of antiviral agents in hepatitis C virus. Hepatology. 2014 May; 59(5):1688-91.
    View in: PubMed
    Score: 0.015
  12. Expanding access to hepatitis C virus care: a call to deconstruct individualized therapy. Hepatology. 2014 Jan; 59(1):13-5.
    View in: PubMed
    Score: 0.015
  13. Impact of age on viral kinetics of peginterferon alfa-2a/ribavirin in chronic hepatitis C: final analysis from the PROPHESYS cohort. J Viral Hepat. 2014 May; 21(5):377-80.
    View in: PubMed
    Score: 0.015
  14. Is the HCV pipeline heading in the right direction? Gastroenterology. 2013 Mar; 144(3):482-5.
    View in: PubMed
    Score: 0.014
  15. Informed deferral: a moral requirement for entry into the hepatitis C virus treatment warehouse. Hepatology. 2012 Nov; 56(5):1591-2.
    View in: PubMed
    Score: 0.014
  16. Distributive justice and the arrival of direct-acting antivirals: who should be first in line? Hepatology. 2011 Jun; 53(6):1789-91.
    View in: PubMed
    Score: 0.013
  17. Hepatobiliary manifestations of critically ill and postoperative patients. Clin Liver Dis. 2011 Feb; 15(1):183-97.
    View in: PubMed
    Score: 0.012
  18. Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Hepatology. 2020 02; 71(2):686-721.
    View in: PubMed
    Score: 0.012
  19. Long-term outcomes after treatment with interferon and ribavirin in HCV patients. J Clin Gastroenterol. 2009 Aug; 43(7):661-71.
    View in: PubMed
    Score: 0.011
  20. Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host Microbe. 2024 Jan 10; 32(1):117-130.e4.
    View in: PubMed
    Score: 0.008
  21. HepCCATT: a multilevel intervention for hepatitis C among vulnerable populations in Chicago. J Public Health (Oxf). 2022 12 01; 44(4):891-899.
    View in: PubMed
    Score: 0.007
  22. Liver Transplantation of HCV-viremic Donors Into HCV-negative Recipients in the United States: Increasing Frequency With Profound Geographic Variation. Transplantation. 2021 06 01; 105(6):1285-1290.
    View in: PubMed
    Score: 0.006
  23. How to Integrate a Medical Ethics Curriculum into Gastroenterology Fellowships. Gastroenterology. 2021 03; 160(4):1003-1006.
    View in: PubMed
    Score: 0.006
  24. A Rare Case of an Aggressive Liver Tumor. Clin Gastroenterol Hepatol. 2021 07; 19(7):e72.
    View in: PubMed
    Score: 0.006
  25. The benefit of paracentesis on hospitalized adults with cirrhosis and ascites. J Gastroenterol Hepatol. 2016 May; 31(5):1025-30.
    View in: PubMed
    Score: 0.004
  26. Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection. PLoS Pathog. 2015 Dec; 11(12):e1005325.
    View in: PubMed
    Score: 0.004
  27. A call to action: The need for hepatology-focused educational interventions in Internal Medicine Residency training. Hepatology. 2015 Aug; 62(2):655-6.
    View in: PubMed
    Score: 0.004
  28. Screening for Zinc Deficiency in Patients with Cirrhosis: When Should We Start? Dig Dis Sci. 2015 Oct; 60(10):3130-5.
    View in: PubMed
    Score: 0.004
  29. Do colorectal cancer patients understand that their family is at risk? Dig Dis Sci. 2009 Nov; 54(11):2473-83.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.